Extracardiac Doppler indices predict perinatal mortality in fetuses with Ebstein anomaly and tricuspid valve dysplasia. (9th January 2021)

• Record Type: Journal Article
• Authors: Wang, Shuo; Freud, Lindsay R.; Detterich, Jon; Moon‐Grady, Anita J.; Donofrio, Mary T.; Jaeggi, Edgar T.; Szwast, Anita L.; Morris, Shaine A.; Kavanaugh‐Mchugh, Ann; Howley, Lisa W.; van der Velde, Mary E.; Cuneo, Bettina F.; Phoon, Colin K.; Tworetzky, Wayne; Pruetz, Jay D.
• Is Part Of: Prenatal diagnosis. Volume 41:Number 3(2021)
• Page Start: 332
• Page End: 340
• Publication Date: 2021-01-09
• Subjects: Prenatal diagnosis -- Periodicals; Fetus -- Diseases -- Diagnosis -- Periodicals; Electronic journals; 618.32075
• DOI: 10.1002/pd.5873
• Languages: English
• ISSNs: 0197-3851

Abstract

Abstract: Objectives: Ebstein anomaly and tricuspid valve dysplasia (EA/TVD) carry high perinatal mortality. Past studies have focused on cardiac predictors of mortality; we sought to describe the fetal echo (FE) extracardiac Dopplers in this cohort and determine their association with perinatal mortality. Method: Fetuses with EA/TVD at 23 centers from 2005–2011 were included for retrospective study. Doppler pattern and velocity of the umbilical artery (UA), umbilical vein (UV), ductus venosus (DV), and middle cerebral artery (MCA) were collected. Bivariate and multivariate analyzes were performed. The primary outcome measure was perinatal mortality, defined as fetal demise or neonatal death. Results: Of 190 cases that met eligibility criteria, alterations were seen in 50% of UA, 16% of UV, 48% of DV, and 8% of MCA Doppler indices on the last FE (median 27.4 weeks). Independent predictors of perinatal mortality included abnormal UA Doppler pattern of absence or reversed end diastolic flow (OR 9.7) and UV velocity z score <1 (OR 2.5), in addition to diagnosis <32 weeks (OR 4.2) and tricuspid valve (TV) annulus z score ≥6 (OR 5.3). Conclusion: Abnormal UA Doppler pattern and decreased UV velocity are independent predictors of perinatal mortality in EA/TVD fetuses and should be used to refine mortality risk and guide perinatal management.